Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Rancho Cucamonga, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Amphastar Pharmaceuticals, Inc. has filed 950 SEC EDGAR filings since 11 Feb 2005

SEC filing history

Showing 376-400 of 941 matching filings.

Per page
25
Current page
16
SC 13G/A File 005-88204

SC 13G/A

Filing date
11 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
09 Feb 2022
Reporting date
08 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
09 Feb 2022
Reporting date
08 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88204

SCHEDULE 13G/A

Filing date
09 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
02 Feb 2022
Reporting date
01 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88204

SC 13G/A filing

Filing date
28 Jan 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
11 Jan 2022
Reporting date
10 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
11 Jan 2022
Reporting date
07 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
04 Jan 2022
Reporting date
03 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
04 Jan 2022
Reporting date
30 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
23 Dec 2021
Reporting date
22 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
22 Dec 2021
Reporting date
21 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
17 Dec 2021
Reporting date
16 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
13 Dec 2021
Reporting date
10 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
23 Nov 2021
Reporting date
22 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-260916

EFFECT filing

Filing date
19 Nov 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
17 Nov 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
15 Nov 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
12 Nov 2021
Reporting date
11 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
12 Nov 2021
Reporting date
11 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-260916

S-3

Filing date
09 Nov 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .